Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06462664

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia

Status
Recruiting
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro

Conditions

Timeline

Start date
2024-06-01
Primary completion
2028-01-31
Completion
2028-01-31
First posted
2024-06-17
Last updated
2024-06-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06462664. Inclusion in this directory is not an endorsement.

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM) (NCT06462664) · Clinical Trials Directory